SCHEMBL19503725

SCHEMBL19503725

CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NSc4ccc(NCCSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1

nearest known ligand 0.62

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 17/20 0.62
▸ BCL2L1 Q07817 14/20 0.62
▸ BCL2L2 Q92843 2/20 0.62
▸ BAD Q92934 2/20 0.62
▸ BCL2L11 O43521 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ MCL1 Q07820 1/20 0.62
▸ ASPH Q12797 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19503604 0.96 BCL2 (0.56) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL19503603 0.95 BCL2 (0.56) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL22295609 0.90 BCL2L1 (0.76) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL19014640 0.90 BCL2 (0.61) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL22295589 0.89 BCL2 (0.62) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL19014638 0.83 BCL2 (0.67) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL29077589 0.82 BCL2 (0.79) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL19244593 0.81 BCL2 (0.76) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL19014717 0.81 BCL2L1 (0.69) BCL2BCL2L1BCL2L2BADBCL2L11
SCHEMBL29321403 0.81 BCL2L1 (0.62) BCL2BCL2L1BCL2L2BADBCL2L11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081880-A1 COMPOSITIONS TARGETING SENESCENT CELLS AND THE USES THEREOF BIOVENTURES, LLC (US) 2020-04-23 — — WO disclosed
WO-2017184995-A1 COMPOUNDS THAT INDUCE DEGRADATION OF ANTI-APOPTOTIC BCL-2 FAMILY PROTEINS AND THE USES THEREOF BIOVENTURES, LLC (US) 2017-10-26 — — WO disclosed
Send feedback